Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Collins

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Genes, Chromosomes & Cancer|January 21, 2004
Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysisHerman van Dekken, Pamela L Paris, Donna G Albertson, et al.
Oncotarget|June 5, 2015
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapiesWolfgang Jäger, Hui Xue, Tetsutaro Hayashi, et al.
Scientific Reports|February 17, 2017
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapyBernhard Kiss, Alexander W Wyatt, James Douglas, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 28, 2004
Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridizationMark van Duin, Ronald van Marion, J E Vivienne Watson, et al.
Iscience|July 5, 2022
Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancerZiwei Wang, Tao Wang, Danni Hong, et al.
Cell Genomics|June 11, 2025
CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of RESTLiangliang Liu, Itzel Astiazarán Rascón, Dong Lin, et al.
European Urology|March 17, 2018
Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate CancerJun Hao, Xinpei Ci, Hui Xue, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Atrial Fibrillation Related Titin Truncation Is Associated With Atrial Myopathy in Patient-Derived Induced Pluripotent Stem Cell Disease ModelsKate Huang, Mishal Ashraf, Leili Rohani, et al.
Oncogene|March 10, 2004
Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancerJ E Vivienne Watson, Norman A Doggett, Donna G Albertson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate CancerMannan Nouri, Shabnam Massah, Josselin Caradec, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Genes, Chromosomes & Cancer|January 21, 2004
Evaluation of genetic patterns in different tumor areas of intermediate-grade prostatic adenocarcinomas by high-resolution genomic array analysisHerman van Dekken, Pamela L Paris, Donna G Albertson, et al.
Oncotarget|June 5, 2015
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapiesWolfgang Jäger, Hui Xue, Tetsutaro Hayashi, et al.
Scientific Reports|February 17, 2017
Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapyBernhard Kiss, Alexander W Wyatt, James Douglas, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 28, 2004
Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridizationMark van Duin, Ronald van Marion, J E Vivienne Watson, et al.
Iscience|July 5, 2022
Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancerZiwei Wang, Tao Wang, Danni Hong, et al.
Cell Genomics|June 11, 2025
CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of RESTLiangliang Liu, Itzel Astiazarán Rascón, Dong Lin, et al.
European Urology|March 17, 2018
Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate CancerJun Hao, Xinpei Ci, Hui Xue, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Atrial Fibrillation Related Titin Truncation Is Associated With Atrial Myopathy in Patient-Derived Induced Pluripotent Stem Cell Disease ModelsKate Huang, Mishal Ashraf, Leili Rohani, et al.
Oncogene|March 10, 2004
Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancerJ E Vivienne Watson, Norman A Doggett, Donna G Albertson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate CancerMannan Nouri, Shabnam Massah, Josselin Caradec, et al.
Pageof 9